Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

v3.21.1
Shareholders' Deficit (Tables)
3 Months Ended
Mar. 31, 2021
Equity [Abstract]  
Schedule of Preferred Stock

The Company has authorized 5,000,000 shares of preferred stock which have been designated as follows:

 

    Number of Shares     Number of Shares Outstanding     Par     Liquidation  
    Authorized     at September 30, 2020     Value     Value  
Series AA     1,000,000       25,000     $ 0.0010     $ -  
Preferred Series B     50,000       600     $ 0.0001     $ 100  
Preferred Series C     8,000       763     $ 0.0001     $ 1,000  
Preferred Series D     20,000       305     $ 0.0001     $ 1,000  
Undesignated     3,922,000       -       -       -  
Schedule of Stock Options Outstanding

The balance of all stock options outstanding as of March 31, 2021, is as follows:

 

          Weighted
Average
    Weighted
Average
Remaining
    Aggregate  
          Exercise Price     Contractual     Intrinsic  
    Options     Per Share     Term (years)     Value  
Outstanding at January 1, 2021     3,014,080     $ 0.37       1.67             -  
Granted     -     $ -       -       -  
Cancelled     (350 )   $ 47.00       -       -  
Exercised     -     $ -       -       -  
Outstanding at March 31, 2021     3,013,730     $ 0.37       2.79     $ -  
                                 
Exercisable at March 31, 2021     763,730     $ 1.01       1.72     $ -  
Schedule of Warrants Outstanding

A summary of the status of the warrants granted under these agreements at March 31, 2021, and changes during the three months then ended is presented below:

 

    Outstanding Warrants        
          Weighted Average     Weighted Average Remaining  
          Exercise Price     Contractual  
    Shares     Per Share     Term (years)  
Outstanding at January 1, 2021     39,295     $ 200.72       0.93  
Granted     -     $ -       -  
Cancelled     (8,770 )   $ 510.04       -  
Exercised     -     $ -          
Outstanding at March 31, 2021     30,525     $ 111.86       0.90  
                         
Exercisable at March 31, 2021     30,525     $ 111.86       0.90